ArticleFrontiers in medicine2023

Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker.

Caroline Burgard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.